Gene Editing The FDA further expands collaboration with CN Bio to evaluate the PhysioMimix Multi-organ microphysiological system Posted on January 17, 2023 by Editorial Staff Expansion of five-year collaboration broadens established Organ-on-a-chip research demonstrating advanced performance of the PhysioMimix MPS. Share on FacebookTweetFollow us Editorial Staff Opinion: STAT+: 4 concrete steps to realize the AI Bill of Rights for clinical decision support software Optibrium appoints Steve Yemm as Chief Commercial Officer